Cytosorbents Corp (15)

Browse by Contract Category

Contracts

Third Amendment to the Amended and Restated Loan and Security Agreement, dated December 4, 2020 (Filed With SEC on December 10, 2020)
Nineteenth Amendment to Lease Agreement by and between the Registrant and Princeton Corporate Plaza, LLC, dated April 16, 2020 (Filed With SEC on August 4, 2020)
Employment Agreement by and between the Company and Efthymios Deliargyris, M.D., dated April 12, 2020 (Filed With SEC on April 27, 2020)
Amendment No. 1 to Open Market Sale AgreementSM, dated as of April 20, 2020, by and among CytoSorbents Corporation, Jefferies LLC and B. Riley FBR, Inc (Filed With SEC on April 20, 2020)
Exclusive Distribution Agreement, dated as of December 15, 2014, by and between CytoSorbents Europe GmbH and Aferetica s.r.l (Filed With SEC on March 7, 2019)
Underwriting Agreement, by and among the Company and the Underwriters, dated as of July 21, 2020 (Filed With SEC on July 22, 2020)
Description of Capital Stock of CytoSorbents Corporation (Filed With SEC on March 5, 2020)
Separation Agreement and Release, dated December 9, 2019, by and between CytoSorbents Corporation and Dr. Eric Mortensen (Filed With SEC on December 12, 2019)
Eighteenth Amendment to Lease Agreement by and between the Registrant and Princeton Corporate Plaza, LLC, dated January 4, 2019 (Filed With SEC on August 6, 2019)
Amended and Restated Employment Agreement, dated as of July 30, 2019, by and between CytoSorbents Medical, Inc. and Phillip P. Chan (Filed With SEC on August 5, 2019)
Amended and Restated Employment Agreement, dated as of July 30 2019, by and between CytoSorbents Medical, Inc. and Vincent Capponi (Filed With SEC on August 5, 2019)
Amended and Restated Employment Agreement, dated as of July 30, 2019, by and between CytoSorbents Medical, Inc. and Kathleen P. Bloch (Filed With SEC on August 5, 2019)
First Amendment to the Amended and Restated Loan and Security Agreement (Filed With SEC on August 5, 2019)
Open Market Sale AgreementSM, dated July 9, 2019, by and among CytoSorbents Corporation, Jefferies LLC and B. Riley FBR, Inc (Filed With SEC on July 9, 2019)
Amendment to Exclusive Distribution Agreement, dated December 15, 2015, by and between CytoSorbents Europe GmbH and Aferetica s.r.l (Filed With SEC on March 7, 2019)